Xarelto Lawsuit Numbers Rise Highlighting New Concern Over Anticoagulant’s Once-Daily Dosing Recommendation

March 22, 2016 – – BloodThinnerHelp.com reports on a lawsuit which was filed against Xarelto manufacturers Janssen Pharmaceuticals (a subdivision of Johnson & Johnson) and Bayer Healthcare in a Pennsylvania State Court. This lawsuit is especially notable as it brings up a new concern that thousands of others have not, indicating that the recommended dosage on the drug (of one pill every 24-hours) is ineffective at protecting patients for a full day.

Xarelto is the only anticoagulant to ever offer a one pill daily dose. Other blood-thinning drugs require 2 pills of medication to be taken each day in order to ensure that the body is properly protected for a full 24-hours. The specific complaints found within this suit state that the drug’s recommended once-daily dose is ineffective for an entire 24-hour period of time. The plaintiff in this notable lawsuit claims just this. He claims to have suffered from a sudden stroke just four days after starting Xarelto. He was prescribed the drug in order to prevent strokes which he was at elevated risk for experiencing due to his atrial fibrillation condition.

Following his stroke, the plaintiff indicates that he decided to file a lawsuit on October 8th of 2015. He named Xarelto manufacturers Bayer and Janssen as his defendants. The lawsuit is the first of its kind to have been filed, though thousands of others have been filed concerning Xarelto and sudden, dangerous bleeding episodes. Not only did the plaintiff allege that Xarelto failed to prevent his stroke, he also claims that the drug may have actually caused the stroke to occur.

Within the last five years, Xarelto has become the topic of over 2,800 lawsuits filed in federal court and over 600 complaints which have been consolidated to form a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania. The anticoagulant drug was approved by the U.S. Food and Drug Administration in 2011 to prevent strokes and blood clots for those recovering from knee and hip replacement surgeries, as well as deep vein thrombosis, pulmonary embolism, or atrial fibrillation.

Those who have now filed federal Xarelto lawsuits have had their cases transferred and consolidated by the U.S. Judicial Panel on Multidistrict Litigation to form MDL No. 2592 in a single court in Eastern Louisiana. Lawsuits involved in MDL 2592 are being overseen by the Honorable Judge Eldon E. Fallon.

While the plaintiffs involved in these cases anxiously await justice, lawsuit numbers continue to grow. Attorney Joseph Osborne is working to help ensure that anyone suffering from medical problems after taking Xarelto will be provided the important opportunity to explore their legal rights in full. To help those wishing to pursue justice, Attorney Osborne is currently offering free consultations to affected parties, who could be entitled to significant compensation through legal action.

To ask questions, or request additional Xarelto lawsuit information, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008819